Marksans Pharma gets 5 inspectional observations from USFDA for Goa facility Ruchika Sharma18 April 2024 12:14 PM ISTMumbai: Marksans Pharma has received 5 inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) at...
Marksans Pharma arm gets marketing authorisation for Cyanocobalamin 50mg film coated tablets from UK MHRA Ruchika Sharma6 Nov 2023 4:30 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorisation for the...
Marksans Pharma arm receives EIR from USFDA Ruchika Sharma4 Nov 2023 12:30 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Time-Cap Laboratories, Inc. has received Establishment Inspection...
Marksans Pharma Goa facility undergoes successful inspection from German Health Authorities Ruchika Sharma2 Nov 2023 5:30 PM ISTMumbai: Marksans Pharma Limited has recently announced that the Company's newly acquired Goa manufacturing facility has successfully undergone...
Marksans Pharma bags USFDA nod for Esomeprazole Magnesium Delayed Release Capsules Ruchika Sharma4 Oct 2023 11:31 AM ISTEsomeprazole is used to treat certain stomach and esophagus problems (such as acid reflux and ulcer).
Marksans Pharma Mucus loosening drug Guaifenesin ER bags USFDA okay Ruchika Sharma22 Aug 2023 4:50 PM ISTGuaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus...
Marksans Pharma gets 2 USFDA observations for Goa facility Ruchika Sharma7 Aug 2023 3:15 PM ISTMumbai: Marksans Pharma has announced that the United State Food and Drug Administration (USFDA) has completed a Post-marketing Adverse Drug...
Marksans Pharma bags USFDA nod for Acetaminophen, Ibuprofen Tablets Ruchika Sharma12 July 2023 12:31 PM ISTThe pivotal approval, Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg provides relief for multiple pain-related symptoms by combining two powerful...
Marksans Pharma concludes acquisition of Tevapharm India's Goa manufacturing site Ruchika Sharma20 April 2023 1:30 PM ISTThe acquired facility will enable Marksans Pharma to potentially double the existing Indian capacity from 8bn units per annum currently.
USFDA nod to Marksans Pharma Famotidine Tablets for OTC use Ruchika Sharma10 March 2023 1:15 PM ISTMumbai: Marksans Pharma Limited has announced that the company has received final approval from US Food & Drugs Administration (USFDA) for its...
Marksans Pharma subsidiary gets UK MHRA okay for Fluoxetine 20mg/5ml Oral Solution Ruchika Sharma25 Jan 2023 2:27 PM ISTMumbai: Marksans Pharma Limited has announced that UK MHRA has granted market authorisation to the Company's wholly owned subsidiary Relonchem Limited...
Marksans Pharma plans to double manufacturing capacity with acquisition of Tevapharm India bulk formulations business Ruchika Sharma12 Oct 2022 11:15 AM ISTMarksans plans to manufacture tablets, hard and soft gel capsules, ointments, gummies, and creams, from the new capacity.
